| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aptose Biosciences Inc. | Director | Director Stock Option (Right to Buy) | 3,333 | 05 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| APTOF | Aptose Biosciences Inc. | 05 Feb 2024 | 1 | $0 | 4 | Director | 07 Feb 2024, 16:52 |
| APTOF | Aptose Biosciences Inc. | 19 Jan 2023 | 1 | $0 | 4 | Director | 23 Jan 2023, 18:58 |
| APTOF | Aptose Biosciences Inc. | 18 Jan 2022 | 1 | $0 | 4 | Director | 20 Jan 2022, 16:11 |
| APTOF | Aptose Biosciences Inc. | 16 Dec 2021 | 3 | +$137,900 | 4 | Director | 20 Dec 2021, 15:33 |
| APTOF | Aptose Biosciences Inc. | 15 Dec 2021 | 4 | +$316,340 | 4 | Director | 17 Dec 2021, 12:45 |